Table 2 Prevalence of silent cerebral infarcts in HbSS and HbSβ0 sickle cell disease patients
From: Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis
Author (year) | Study design | Sample size | Mean age (years) | Field strength (T) | Prevalence SCIs (%) |
|---|---|---|---|---|---|
Abboud et al. 2011 [19] | PCS | 77 | 12.3 | NA | 26.6 |
Arkuszewski et al. 2014 [20] | PCS | 67 | 8.8 | 3.0 | 37.7 |
Asbeutah et al. 2014 [21] | PCS | 40 | 10.1* | 1.5 | 10 |
de Blank et al. 2010 [24] | RCS | 254 | 10.6 | NA | 30.7 |
Brousse et al. 2017 [25] | PCS | 59 | 11.4 | NA | 13.6 |
Brown et al. 2000 [26] | PCS | 48 | 9.8* | NA | 22.9 |
Calvet et al. 2017 [27] | RCS | 83 | 43.3 | 3.0 | 49.4 |
Ford et al. 2017 [30] | PCS | 22 | 27 | NA | 54.5 |
Ford et al. 2018 [31] | PCS | 1061 | NA | NA | 27 |
Guilliams et al. 2015 [33] | RCS | 168 | NA | 1.5/3.0 | 27.4 |
Gyang et al. 2011 [34] | RCS | 8 | 15 | NA | 50 |
Kassim et al. 2016 [36] | RCS | 60 | 30 | NA | 53.3 |
Kwiatkowski et al. 2009 [6] | RCS | 65 | 3.6 | 1.5 | 27.7 |
Marouf et al. 2003 [67] | PCS | 35 | 26.9 | NA | 20 |
Mercuri et al. 1995 [39] | PCS | 11 | 9.3 | 1.0 | 45.5 |
Nottage et al. 2016 [68] | PCS | 50 | 9.4 | NA | 38 |
Oguz et al. 2003 [40] | PCS | 18 | 8.7 | 1.5 | 5.6 |
Pegelow et al. 2002 [10] | RCS | 266 | 8.3* | NA | 21.8 |
Schatz et al. 2005 [44] | PCS | 20 | 12.2** | 1.5 | 40 |
Silva et al. 2009 [46] | PCS | 46 | 26.8 | 1.5 | 56.5 |
Tewari et al. 2018 [49] | PCS | 51 | 12.4** | NA | 37.3 |
Václavů et al. 2019 [50] | PCS | 36 | 31.9 | 3.0 | 80.6 |
Van der Land et al. 2015 [51] | PCS | 10 | 23 | 3.0/7.0 | 50 |
Van der Land et al. 2016 [52] | PCS | 34 | 12.1 | 3.0 | 41.2 |
Vichinsky et al. 2010 [53] | PCS | 141 | 31.6 | 1.5 | 28.9 |
Wang et al. 1998 [54] | PCS | 36 | 1.5 | 1.5 | 8.3 |
Wang et al. 2008 [55] | PCS | 23 | 1.1 | 1.5 | 13 |